BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8727912)

  • 1. Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting.
    Sorrell TC; Chen SC; Ruma P; Meyer W; Pfeiffer TJ; Ellis DH; Brownlee AG
    J Clin Microbiol; 1996 May; 34(5):1253-60. PubMed ID: 8727912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural environmental sources of Cryptococcus neoformans var. gattii.
    Sorrell TC; Brownlee AG; Ruma P; Malik R; Pfeiffer TJ; Ellis DH
    J Clin Microbiol; 1996 May; 34(5):1261-3. PubMed ID: 8727913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts.
    Chen SC; Currie BJ; Campbell HM; Fisher DA; Pfeiffer TJ; Ellis DH; Sorrell TC
    Trans R Soc Trop Med Hyg; 1997; 91(5):547-50. PubMed ID: 9463664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro.
    Igreja RP; Lazéra Mdos S; Wanke B; Galhardo MC; Kidd SE; Meyer W
    Med Mycol; 2004 Jun; 42(3):229-38. PubMed ID: 15283237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
    Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
    Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
    Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
    PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification by random amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var. neoformans in patients with AIDS or other immunosuppressive conditions.
    Chen SC; Brownlee AG; Sorrell TC; Ruma P; Nimmo G
    J Infect Dis; 1996 Mar; 173(3):754-8. PubMed ID: 8627047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic grouping of Cryptococcus neoformans var. gattii by random amplified polymorphic DNA fingerprint patterns and ITS sequence divergence.
    Imai T; Watanabe K; Tamura M; Mikami Y; Tanaka R; Nishimura K; Miyaji M; Poonwan N; Branchini ML
    Clin Lab; 2000; 46(7-8):345-54. PubMed ID: 10934581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of Cryptococcus neoformans var. neoformans serotype D from Eucalypts in South Brazil.
    Medeiros Ribeiro A; Silva LK; Silveira Schrank I; Schrank A; Meyer W; Henning Vainstein M
    Med Mycol; 2006 Dec; 44(8):707-13. PubMed ID: 17127627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New PCR primer pairs specific for Cryptococcus neoformans serotype A or B prepared on the basis of random amplified polymorphic DNA fingerprint pattern analyses.
    Aoki FH; Imai T; Tanaka R; Mikami Y; Taguchi H; Nishimura NF; Nishimura K; Miyaji M; Schreiber AZ; Branchini ML
    J Clin Microbiol; 1999 Feb; 37(2):315-20. PubMed ID: 9889210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryplococcal Disease Active Surveillance Group.
    Brandt ME; Hutwagner LC; Kuykendall RJ; Pinner RW
    J Clin Microbiol; 1995 Jul; 33(7):1890-5. PubMed ID: 7665665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group.
    Brandt ME; Hutwagner LC; Klug LA; Baughman WS; Rimland D; Graviss EA; Hamill RJ; Thomas C; Pappas PG; Reingold AL; Pinner RW
    J Clin Microbiol; 1996 Apr; 34(4):912-7. PubMed ID: 8815107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ; Wu HC; Hsueh PR
    Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
    González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
    Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass.
    Kidd SE; Sorrell TC; Meyer W
    Med Mycol; 2003 Apr; 41(2):171-6. PubMed ID: 12964851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil.
    Trilles L; Lazéra Mdos S; Wanke B; Oliveira RV; Barbosa GG; Nishikawa MM; Morales BP; Meyer W
    Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):455-62. PubMed ID: 18797758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey.
    Meyer W; Marszewska K; Amirmostofian M; Igreja RP; Hardtke C; Methling K; Viviani MA; Chindamporn A; Sukroongreung S; John MA; Ellis DH; Sorrell TC
    Electrophoresis; 1999 Jun; 20(8):1790-9. PubMed ID: 10435451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular typing of Cryptococcus neoformans: taxonomic and epidemiological aspects.
    Boekhout T; van Belkum A; Leenders AC; Verbrugh HA; Mukamurangwa P; Swinne D; Scheffers WA
    Int J Syst Bacteriol; 1997 Apr; 47(2):432-42. PubMed ID: 9103633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.